-
Interventional Glaucoma—Evolved Care for Preserving Vision
Less patient burden. Less dependence on drops. Less risk of patients lapsing out of care. Discover why Interventional Glaucoma (IG) is the evolved standard of care. It is a proactive, procedure-first approach that puts physicians in control of glaucoma management by reducing reliance on drop therapy—potentially improving patient outcomes and helping prevent glaucoma-related blindness.
-
Interventional Glaucoma Month
IG Month was created to rally the eyecare community, patients, and caregivers around a more proactive future for glaucoma care. Focused on moving beyond drop dependence because 2 out of 3 patients ultimately lapse in care;2 the initiative raises awareness of earlier, interventional treatment designed to preserve vision before irreversible damage occurs.
-
A Global Movement. Starts September 12th.
GIG Day is not just a movement; it’s a shift in mindset from watchful waiting to proactive and empowered with IG. Together, we are redefining how specialists detect, treat, and talk about glaucoma earlier in the patient journey.
Move beyond drop-dependent care
2 of 3 Patients on Glaucoma Drops Lapse Out of Care2
Once patients leave your chair, control over their drop therapy becomes limited. Daily long-term drop therapy can be difficult for many patients to sustain. Complex multi-drop regimens and side effects such as burning and dryness can lead to medication nonadherence and preventable lapses in care.3
>90%
of patients are noncompliant with medication use.4,5,6
50%
of patients discontinue their medication within 6 months.2
65%
of patients managed on topical drops lapse out of care at 12 months.2,4
Without Continuity of Care, Patients More Than Double Their Risk for Vision Loss:
-
2.17x higher risk of blindness
among glaucoma patients absent from care for more than 3 years.8
-
62%
of patients on drops who lapse do not return within 3 years.7
Help Preserve Vision With Interventional Glaucoma1
Interventional Glaucoma is a procedure-first approach designed to reduce dependence on chronic drop therapy. Patients managed with an interventional approach are twice as likely to maintain follow-up visits and receive AAO-recommended visual field testing.1
How an interventional approach advances patient care:
-
Personalized
Glaucoma management informed by early predictive diagnostics and active monitoring.
-
Proactive
Treatment decisions made before significant progression occurs or patient adherence challenges compromise care.
-
Effective
Early procedural interventions help HCPs maintain greater control of glaucoma management and preserve vision.